Literature DB >> 11796311

Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate.

Manabu Ishigooka1, Teruhiro Nakada, Tohru Hashimoto, Yoshiaki Iijima, Hiromasa Yaguchi.   

Abstract

OBJECTIVES: To investigate the role substance P (SP) plays in prostatic inflammation, we evaluated SP immunoreactivity within the spinal cord after irritation of the prostate. Because alpha-adrenergic blockade attenuates nociceptor-induced pain, the effects of an alpha-adrenergic blocker on SP immunoreactivity were also evaluated. SP is considered a mediator of nociception in the spinal cord. Immunoreactivity of SP is enhanced after acute chemical stimulation of somata.
METHODS: Rats received chemical irritation of the prostate with or without pretreatment with tamsulosin. They were killed after 1 hour, and immunohistochemical staining for SP was performed. SP immunoreactive areas were quantified in the dorsal spinal cord of the L5 to S2 segments.
RESULTS: Chemical irritation of the prostate increased SP immunoreactive areas in the L6 to S2 segments. Enhancement was observed in the whole dorsal spinal cord regions. This enhancement was significantly attenuated by tamsulosin in the L6 and S1 segments.
CONCLUSIONS: SP probably plays a significant role in mediating nociceptive processing from the prostate. Tamsulosin can attenuate nociception-induced SP upregulation within the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796311     DOI: 10.1016/s0090-4295(01)01470-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.

Authors:  Yong Chen; Xiaohou Wu; Jia Liu; Wei Tang; Tao Zhao; Jianhua Zhang
Journal:  World J Urol       Date:  2010-03-25       Impact factor: 4.226

2.  Expression and Regulation of Brain Natriuretic Peptide and Natriuretic Peptide Receptor A (NPR-A) in L6-S1 Dorsal Root Ganglia in a Rat Model of Chronic Nonbacterial Prostatitis.

Authors:  Xiaorong Yang; Qiang Chen; Ming Ma; Wenjie Xie; Binbin Gong; Yongming Huang; Yu Li; Shuangmei Liu; Jieping Hu; Shangdong Liang; Jie Chen; Fang Liu; Ting Sun
Journal:  Med Sci Monit       Date:  2019-11-28

3.  Management of ureteral calculi and medical expulsive therapy in emergency departments.

Authors:  Stefano C M Picozzi; Carlo Marenghi; Stefano Casellato; Cristian Ricci; Maddalena Gaeta; Luca Carmignani
Journal:  J Emerg Trauma Shock       Date:  2011-01

Review 4.  New therapies in chronic prostatitis.

Authors:  Nivedita Bhatta Dhar; Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 5.  Treatment response to conventional and novel therapies in chronic prostatitis.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 6.  Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.

Authors:  María L Breser; Florencia C Salazar; Viginia E Rivero; Rubén D Motrich
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

7.  Effects of Electroacupuncture on Alleviating Prostatodynia and Inflammation in Rats with Chronic Nonbacterial Prostatitis.

Authors:  Chao Zhang; Ding Li
Journal:  J Pain Res       Date:  2021-09-07       Impact factor: 3.133

8.  Current treatment options in the management of chronic prostatitis.

Authors:  Alain Jean Duclos; Chun-Te Lee; Daniel Arthur Shoskes
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

9.  Activated spinal astrocytes contribute to the later phase of carrageenan-induced prostatitis pain.

Authors:  Guo-Chuang Deng; Ming Lu; Ya-Yu Zhao; Ying Yuan; Gang Chen
Journal:  J Neuroinflammation       Date:  2019-10-25       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.